Search - tctmd.com

Displaying 281 - 300 of 423

Sort: Relevancy | Date

Presentation CCVVC 2015

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Presenter: Craig M. Walker

June 18, 2015

Presentation

Long-term Efficacy and Safety of Paclitaxel-Eluting Balloon (PEB) for the Treatment of DES Restenosis

Presenter: Sebastian Kufner

June 02, 2015

Presentation Fellows 2015

Stent Thrombosis and Restenosis

Presenter: Duane S. Pinto, Tamim Nazif, Ajay J. Kirtane

May 16, 2015

Presentation Intravascular Coronary Imaging and Physiology 2015

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

April 18, 2015

Presentation ARCH 2015

How to Approach In-Stent Restenosis

Presenter: Craig M. Walker

April 10, 2015

Presentation

Paclitaxel-Coated Balloon Catheter Compared With DES for DES Restenosis in Routine Clinical Practice

Presenter: S Habara

March 01, 2015

Presentation

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Presenter: MA Magalhaes

December 11, 2014

Presentation

Prognostic Role of Restenosis in 10,004 Patients Undergoing Routine Control Angiography

Presenter: S. Cassese

October 21, 2014

Presentation

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Presenter: Monika Herten

October 16, 2014

Presentation TCT 2014

Restenosis of the Ostial Circumflex: How to Prevent and How to Treat

Presenter: Andrejs Erglis, Nicholas J. Lembo, Hadley K. Wilson, Fernando Alfonso

September 16, 2014

Presentation TCT 2014

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Freek Nijhoff

September 16, 2014

Presentation TCT 2014

Left Main Restenosis: Frequency, Implications, and Management

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Adrian P. Banning

September 16, 2014

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Presentation TCT 2014

Optimized Immediate Angiographic Result After Percutaneous Coronary Intervention for Chronic Total Occlusion Is Associated With Lower Restenosis Rates_ A Single Centre Experience_

Presenter: Karl ISAAZ

September 16, 2014

Presentation TCT 2014

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Presenter: Bruno Scheller

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Ning Guo

September 15, 2014

Presentation TCT 2014

Case #8: Early Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Neal Uren

September 15, 2014

Presentation TCT 2014

Case #7: In-Stent Restenosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Bernhard Witzenbichler

September 15, 2014

Presentation TCT 2014

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Presenter: Soo-Jin Kang, Akiko Maehara, Gary S. Mintz, Fernando Alfonso

September 15, 2014

Advertisement

Endovascular Management of SFA Instent Restenosis: Role of Atherectomy Drug-Eluting Stents

Long-term Efficacy and Safety of Paclitaxel-Eluting Balloon (PEB) for the Treatment of DES Restenosis

Stent Thrombosis and Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

How to Approach In-Stent Restenosis

Paclitaxel-Coated Balloon Catheter Compared With DES for DES Restenosis in Routine Clinical Practice

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Prognostic Role of Restenosis in 10,004 Patients Undergoing Routine Control Angiography

DEBs for Femoropopliteal Lesions Show Better Performance in De Novo Stenosis Than Restenosis

Restenosis of the Ostial Circumflex: How to Prevent and How to Treat

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

Left Main Restenosis: Frequency, Implications, and Management

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Optimized Immediate Angiographic Result After Percutaneous Coronary Intervention for Chronic Total Occlusion Is Associated With Lower Restenosis Rates_ A Single Centre Experience_

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Practical Integration: A Modern Cath Lab-Based Imaging Service (and Lessons Learned)

Case #8: Early Stent Thrombosis

Case #7: In-Stent Restenosis

Mechanisms, Predictors, and Unusual Causes of Early, Late, and Very Late Stent Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content